Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Valneva Se ADR (VALN)

Valneva Se ADR (VALN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 892,930
  • Shares Outstanding, K 86,107
  • Annual Sales, $ 183,500 K
  • Annual Income, $ -13,250 K
  • EBIT $ -6 M
  • EBITDA $ 36 M
  • 60-Month Beta 1.83
  • Price/Sales 4.16
  • Price/Cash Flow 102.70
  • Price/Book 4.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.49
  • Number of Estimates 1
  • High Estimate -0.49
  • Low Estimate -0.49
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +9.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.02 +25.69%
on 12/19/25
10.37 -2.80%
on 01/14/26
+1.48 (+17.21%)
since 12/15/25
3-Month
8.02 +25.69%
on 12/19/25
10.55 -4.45%
on 10/16/25
-0.42 (-4.00%)
since 10/15/25
52-Week
4.22 +138.86%
on 01/16/25
12.25 -17.71%
on 08/19/25
+5.77 (+133.87%)
since 01/15/25

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Valneva SE (" Valneva " or the "Company") ( NASDAQ : VALN ). Such...

VALN : 10.08 (-2.80%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised to contact...

VALN : 10.08 (-2.80%)
Kepler Capital Sticks to Its Buy Rating for Valneva (0OB3)

In a report released on October 7, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva, with a price target of €7.70. The company’s shares closed yesterday at €4.72.Elevate Your...

VALN : 10.08 (-2.80%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , Oct. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised to contact...

VALN : 10.08 (-2.80%)
Valneva Secures $500 Million Financing to Bolster Vaccine Pipeline

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Valneva (...

VALN : 10.08 (-2.80%)
Valneva Reports Long-lasting Antibody Persistence for Chikungunya Vaccine

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

VALN : 10.08 (-2.80%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , Oct. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised to contact...

VALN : 10.08 (-2.80%)
Kepler Capital Sticks to Its Buy Rating for Valneva (0OB3)

Kepler Capital analyst Justine Telliez maintained a Buy rating on Valneva on September 30 and set a price target of €8.10. The company’s shares closed yesterday at €5.13.Elevate Your Investing Strategy:...

VALN : 10.08 (-2.80%)
Ongoing Valneva SE (VALN) Investigation: Protect Your Rights - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - October 1, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Valneva SE ("Valneva SE") (NASDAQ: VALN) concerning possible violations...

VALN : 10.08 (-2.80%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised...

VALN : 10.08 (-2.80%)

Business Summary

Valneva SE is a specialty vaccine company. It is focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva SE is based in Saint-Herblain, France.

See More

Key Turning Points

3rd Resistance Point 10.65
2nd Resistance Point 10.51
1st Resistance Point 10.44
Last Price 10.08
1st Support Level 10.23
2nd Support Level 10.09
3rd Support Level 10.02

See More

52-Week High 12.25
Last Price 10.08
Fibonacci 61.8% 9.18
Fibonacci 50% 8.23
Fibonacci 38.2% 7.29
52-Week Low 4.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar